Home LiteratureArticle Details
PMID: 8331727 Published · ppublish English Journal Article

Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination.

Journal of virology ·Vol. 67 ·No. 8 ·1993-08-00 ·Pages 4732-41

Wolffe EJ, Isaacs SN, Moss B

Abstract

The structure, formation, and function of the virion membranes are among the least well understood aspects of vaccinia virus replication. In this study, we investigated the role of gp42, a glycoprotein component of the extracellular enveloped form of vaccinia virus (EEV) encoded by the B5R gene. The B5R gene was deleted by homologous recombination from vaccinia virus strains IHD-J and WR, which produce high and low levels of EEV, respectively. Isolation of recombinant viruses was facilitated by the insertion into the genome of a cassette containing the Escherichia coli gpt and lacZ genes flanked by the ends of the B5R gene to provide simultaneous antibiotic selection and color screening. Deletion mutant viruses of both strains formed tiny plaques, and those of the IHD-J mutant lacked the characteristic comet shape caused by release of EEV. Nevertheless, similar yields of intracellular infectious virus were obtained whether cells were infected with the B5R deletion mutants or their parental strains. In the case of IHD-J, however, this deletion severely reduced the amount of infectious extracellular virus. Metabolic labeling studies demonstrated that the low extracellular infectivity corresponded with a decrease in EEV particles in the medium. Electron microscopic examination revealed that mature intracellular naked virions (INV) were present in cells infected with mutant virus, but neither membrane-wrapped INV nor significant amounts of plasma membrane-associated virus were observed. Syncytium formation, which occurs in cells infected with wild-type WR and IHD-J virus after brief low-pH treatment, did not occur in cells infected with the B5R deletion mutants. By contrast, syncytium formation induced by antibody to the viral hemagglutinin occurred, suggesting that different mechanisms are involved. When assayed by intracranial injection into weanling mice, both IHD-J and WR mutant viruses were found to be significantly attenuated. These findings demonstrate that the 42-kDa glycoprotein of the EEV is required for efficient membrane enwrapment of INV, externalization of the virus, and transmission and that gp42 contributes to viral virulence in strains producing both low and high levels of EEV.

Related Genes
MeSH Terms
Animals Blotting, Southern Cell Line DNA, Viral/genetics,isolation & purification Escherichia coli/genetics Gene Deletion Gene Products, env/biosynthesis,metabolism Genes, Bacterial Genes, Viral Giant Cells/cytology,physiology HeLa Cells Humans Membrane Glycoproteins/genetics,metabolism Microscopy, Electron Mutagenesis, Insertional Plasmids Recombination, Genetic Restriction Mapping Sequence Deletion Vaccinia virus/genetics,metabolism,ultrastructure Viral Plaque Assay Virion/genetics,metabolism,ultrastructure
Chemicals
DNA, Viral Gene Products, env Membrane Glycoproteins
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Wolffe E J
Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892.
Isaacs S N
Moss B
References (38)
38 references, click to expand
  1. Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope.
    J Virol. 1992 Dec;66(12):7217-24 PMID: 1433514
  2. The complete DNA sequence of vaccinia virus.
    Virology. 1990 Nov;179(1):247-66, 517-63 PMID: 2219722
  3. Dissociation of progeny vaccinia virus from the cell membrane is regulated by a viral envelope glycoprotein: effect of a point mutation in the lectin homology domain of the A34R gene.
    J Virol. 1993 Jun;67(6):3319-25 PMID: 8497053
  4. Inactivated smallpox vaccine: immunogenicity of inactivated intracellular and extracellular vaccinia virus.
    J Gen Virol. 1971 Oct;13(1):19-25 PMID: 5130569
  5. An antigenic difference between intracellular and extracellular rabbitpox virus.
    J Gen Virol. 1971 Oct;13(1):9-17 PMID: 4108676
  6. Biogenesis of poxviruses: role of A-type inclusions and host cell membranes in virus dissemination.
    Virology. 1971 Dec;46(3):507-32 PMID: 4944855
  7. Biogenesis of poxviruses: interrelationship between hemagglutinin production and polykaryocytosis.
    Virology. 1971 Dec;46(3):533-43 PMID: 4109523
  8. Clofibrate-induced antidiuresis.
    J Clin Invest. 1973 Mar;52(3):535-42 PMID: 4685079
  9. Differences between extracellular and intracellular forms of poxvirus and their implications.
    Prog Med Virol. 1973;16:86-108 PMID: 4356899
  10. Neutralizing activities of antisera to poxvirus soluble antigens.
    J Gen Virol. 1974 May;23(2):197-200 PMID: 4833605
  11. Presence of haemagglutinin in the envelope of extracellular vaccinia virus particles.
    J Gen Virol. 1976 Jul;32(1):63-72 PMID: 986420
  12. Vaccinia virus reexamined: development and release.
    Virology. 1976 Aug;73(1):43-58 PMID: 960564
  13. Polypeptide composition of extracellular enveloped vaccinia virus.
    J Virol. 1978 Jul;27(1):28-37 PMID: 691112
  14. Identification of the vaccinia hemagglutinin polypeptide from a cell system yielding large amounts of extracellular enveloped virus.
    J Virol. 1979 Jul;31(1):147-55 PMID: 501796
  15. Assembly of vaccinia virus: role of the intermediate compartment between the endoplasmic reticulum and the Golgi stacks.
    J Cell Biol. 1993 May;121(3):521-41 PMID: 8486734
  16. Regulation of plaque size and host range by a vaccinia virus gene related to complement system proteins.
    Virology. 1991 Mar;181(1):158-64 PMID: 1994573
  17. A mutation in the gene encoding the vaccinia virus 37,000-M(r) protein confers resistance to an inhibitor of virus envelopment and release.
    J Virol. 1991 Jul;65(7):3435-42 PMID: 2041074
  18. Nucleotide sequence of 42 kbp of vaccinia virus strain WR from near the right inverted terminal repeat.
    J Gen Virol. 1991 Jun;72 ( Pt 6):1349-76 PMID: 2045793
  19. Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-Dalton outer envelope protein.
    J Virol. 1991 Nov;65(11):5910-20 PMID: 1920620
  20. Characterization of vaccinia virus glycoproteins by monoclonal antibody precipitation.
    Virology. 1992 Mar;187(1):251-60 PMID: 1736527
  21. Identification and characterization of an extracellular envelope glycoprotein affecting vaccinia virus egress.
    J Virol. 1992 Mar;66(3):1610-21 PMID: 1738204
  22. Molecular attenuation of vaccinia virus: mutant generation and animal characterization.
    J Virol. 1992 May;66(5):2617-30 PMID: 1560521
  23. A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope.
    Virology. 1992 Jun;188(2):801-10 PMID: 1585649
  24. Role of cell-associated enveloped vaccinia virus in cell-to-cell spread.
    J Virol. 1992 Jul;66(7):4170-9 PMID: 1602540
  25. Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia.
    J Gen Virol. 1980 Sep;50(1):89-100 PMID: 7441216
  26. Characterization of intracellular and extracellular vaccinia virus variants: N1-isonicotinoyl-N2-3-methyl-4-chlorobenzoylhydrazine interferes with cytoplasmic virus dissemination and release.
    J Virol. 1981 Sep;39(3):903-13 PMID: 7288920
  27. Extracellular release of enveloped vaccinia virus from mouse nasal epithelial cells in vivo.
    J Gen Virol. 1985 Mar;66 ( Pt 3):643-6 PMID: 3973566
  28. Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype.
    Nature. 1985 Oct 31-Nov 6;317(6040):813-5 PMID: 4058585
  29. Nucleotide sequence of the vaccinia virus hemagglutinin gene.
    Virology. 1986 Apr 30;150(2):451-62 PMID: 3008418
  30. Localization and fine structure of a vaccinia virus gene encoding an envelope antigen.
    J Virol. 1986 Jun;58(3):757-64 PMID: 3701927
  31. A 14,000-Mr envelope protein of vaccinia virus is involved in cell fusion and forms covalently linked trimers.
    J Virol. 1987 Feb;61(2):395-404 PMID: 3806791
  32. Mapping and nucleotide sequence of the vaccinia virus gene that encodes a 14-kilodalton fusion protein.
    J Virol. 1987 Nov;61(11):3550-4 PMID: 2822962
  33. Deletion of the vaccinia virus growth factor gene reduces virus virulence.
    J Virol. 1988 Mar;62(3):866-74 PMID: 3339716
  34. Epitope mosaic on the surface proteins of orthopoxviruses.
    Virology. 1988 Mar;163(1):133-44 PMID: 2450423
  35. Escherichia coli gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors.
    J Virol. 1988 Jun;62(6):1849-54 PMID: 3130492
  36. Hemadsorption and fusion inhibition activities of hemagglutinin analyzed by vaccinia virus mutants.
    Virology. 1990 Apr;175(2):372-84 PMID: 2183466
  37. Vaccinia virus induces cell fusion at acid pH and this activity is mediated by the N-terminus of the 14-kDa virus envelope protein.
    Virology. 1990 Sep;178(1):81-91 PMID: 2389560
  38. Fusion of intra- and extracellular forms of vaccinia virus with the cell membrane.
    J Virol. 1990 Oct;64(10):4884-92 PMID: 2398531
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1993-08-00
Pages
4732-41
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC237859
Subset
IM
Corrections
ErratumIn
-
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com